Yahoo Web Search

  1. Why Is Geron (GERN) Up 27.3% Since Last Earnings Report?

    Zacks via Yahoo FinanceApr 06 13:30 PM

    Following the termination of collaboration with Janssen, a subsidiary of J&Jfor imetelstat development, Geron bears full development cost that was earlier shared equally with Janssen ...

  2. Edited Transcript of LEG.DE earnings conference call or presentation 11-Mar-19 9:00am GMT

    Thomson Reuters StreetEvents via Yahoo FinanceApr 03 14:47 PM

    Board ================================================================================ Conference Call Participants ========================================================================== ...

  3. A Needham analyst sees the return of imetelstat as creating a buying opportunity in Geron. Analyst Chad Messer upgraded Geron from Hold to Buy and introduced a $3 price target. The J&J unit's ...

  4. 4 Drug/Biotech Stocks Making a Mark in RNAi Therapeutics

    Zacks via Yahoo FinanceApr 11 13:27 PM

    Biotech bigwig Regeneron Pharmaceuticals, Inc. s REGN recently extended collaboration agreement with Alnylam Pharmaceuticals, Inc. ALNY brought ribonucleic acid interference (RNAi) therapeutics in focus.

  5. Many of the more than 1,600 opioid lawsuits in state and federal courts name Johnson & Johnson, even though its analgesic products account for less than 1% of the U.S. opioid market. But Oklahoma ...

  6. St. Jude gene therapy cures babies with 'bubble boy' disease

    PR Newswire via Yahoo FinanceApr 17 21:02 PM

    Jude Children's Research HospitalMEMPHIS, Tenn., April 17, 2019 /PRNewswire/ -- Gene therapy developed at St. Jude Children's Research Hospital has cured infants born with X-linked ...

  7. FDA approves first targeted therapy for metastatic bladder cancer

    PR Newswire via Yahoo FinanceApr 12 17:29 PM

    Today's approval represents the first personalized treatment targeting susceptible FGFR genetic alternations for patients with metastatic bladder cancer," said Richard Pazdur, M.D., director ...

  8. Edited Transcript of EVT.DE earnings conference call or presentation 10-May-12 7:30am GMT

    Thomson Reuters StreetEvents via Yahoo FinanceApr 04 6:59 AM

    Having said that, even if it would take out the acquisitions that Evotec made last year, our growth is around 15% versus last year. So the organic...

  9. This kit will be used as a companion diagnostic to identify patients eligible for the treatment with Janssen Biotech’s fibroblast growth factor receptor (FGFR) kinase inhibitor drug, ...

  10. Edited Transcript of JNJ earnings conference call or presentation 16-Apr-19 12:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceApr 17 16:11 PM

    We recently issued our 2018 Janssen U.S. Transparency Report which is now available on our website. We led the industry by publishing this annual report 3 years ago, and we're proud to ...

  1. Ad
    related to Janssen Research